Matrix-directed regulation of pericellular proteolysis and tumor progression

Seminars in Cancer Biology

Volumn 12, Issue 3, 2002, Pages 231-241

  Hornebeck, William ^a   Emonard, Hervé ^a   Monboisse, Jean Claude ^a   Bellon, Georges ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

Author keywords

Elastin; Matrix metalloproteinase 2; Thrombospondin; Tumor invasion; Type IV collagen

Indexed keywords

COLLAGEN TYPE 4; ELASTIN; ENZYME ACTIVATOR; GELATINASE A; INTEGRIN; MATRIX METALLOPROTEINASE; SCAVENGER RECEPTOR; THROMBOSPONDIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; PEPTIDE HYDROLASE;

AGING; ANGIOGENESIS; CANCER CELL; CANCER INVASION; CANCER SURVIVAL; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CELL TYPE; DRUG EFFECT; DRUG PROTEIN BINDING; ENDOCYTOSIS; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MACROMOLECULE; MELANOMA CELL; PROGNOSIS; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN HYDROLYSIS; PROTEIN MOTIF; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVIEW; TUMOR GROWTH; ANIMAL; DISEASE COURSE; ENZYMOLOGY; METABOLISM; NEOPLASM; PATHOLOGY;

ANIMALS; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; HUMANS; MATRIX METALLOPROTEINASE 2; NEOPLASMS; PEPTIDE HYDROLASES;

EID: 0035988813     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1044-579X(02)00026-3     Document Type: Article

References (98)

1. Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2
2. Matrix metalloproteinases and metastasis
3. Matrix metalloproteinases in tumor invasion and metastasis
4. Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts
5. Matrix metalloproteinases: They're not just for matrix anymore!
6. Molecular mechanisms of ageing in connective tissues
7. Proteases in invasion: Matrix metalloproteinases
8. Matrix metalloproteinase substrate binding domains, modules and exosites: Overview and experimental strategies
9. Binding of gelatinases A and B to type I collagen and other matrix components
10. Membrane-type matrix metalloproteinases
11. Membrane type 4 matrix metalloproteinase (MT4-MMP, MMP-17) is a glycosylphosphatidylinositol-anchored proteinase
12. Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase A overexpressed in brain tumors
13. Membrane-type 6 matrix metalloproteinase (MT6-MMP, MMP-25) is the second glycosyl-phosphatidyl inositol (GPI)-anchored MMP
14. How matrix metalloproteinases regulate cell behavior
15. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice
16. Positive and negative transcriptional elements of the human type IV collagenase gene
17. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells
18. Type I collagen stabilization of matrix metalloproteinase-2
19. Extraction of type IV collagenase/gelatinase from plasma membranes of human cancer cells
20. Tumor cell surface-associated binding site for the Mr 72,000 type IV collagenase
21. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3
22. Human MT6-matrix metalloproteinase: Identification, progelatinase A activation, and expression in brain tumors
23. Structural analysis and promoter characterization of the human membrane-type matrix metalloproteinase-1 (MT1-MMP) gene
24. Membrane-type metalloproteinases in tumor invasion
25. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover
26. Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases
27. Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin
28. Structure of human pro-matrix metalloproteinase-2: Activation mechanism revealed
29. Tissue inhibitor of metalloproteinases (TIMP-2). A new member of the metalloproteinase inhibitor family
30. Identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding site on the hemopexin carboxyl domain of human gelatinase A by site-directed mutagenesis. The hierarchical role in binding TIMP-2 of the unique cationic clusters of hemopexin modules III and IV
31. Mechanism of cell surface activation of 72-kDa type IV collagenase: Isolation of the activated form of the membrane metalloprotease
32. Structure and characterization of the human tissue inhibitor of metalloproteinases-2 gene
33. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system
34. Tyrosine 36 plays a critical role in the interaction of the AB loop of tissue inhibitor of metalloproteinases-2 with matrix metalloproteinase-14
35. Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines
36. Membrane associated matrix metalloproteinases in metastasis
37. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion
38. Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7)
39. Pro-collagenase-1 (matrix metalloproteinase-1) binds the α2β1 integrin upon release from keratinocytes migrating on type I collagen
40. Structural analysis of the α2 integrin I domain/procollagenase-1 (matrix metalloproteinase-1) interaction
41. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity
42. Functional activation of integrin αvβ3 in tumor cells expressing membrane-type 1 matrix metalloproteinase
43. MT1-MMP initiates activation of pro-MMP-2 and integrin αvβ3 promotes maturation of MMP-2 in breast carcinoma cells
44. Functional interplay between type I collagen and cell surface matrix metalloproteinase activity
45. Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invapodia is required for cell invasion
46. Cumulative influence of matrix metalloproteinase-1 and -2 in the migration of melanoma cells within three-dimensional type I collagen lattices
47. Caveolins, liquid-ordered domains, and signal transduction
48. MMP-2 colocalizes with caveolae on the surface of endothelial cells
49. Localization of membrane-type 1 matrix metalloproteinase in caveolae membrane domains
50. Involvement of fibronectin type II repeats in the efficient inhibition of gelatinases A and B by long-chain unsaturated fatty acids
51. Basement proteins: Molecular structure and functions
52. Basement membrane (type IV) collagen
53. The role of collagen-derived proteolytic fragments in angiogenesis
54. Bovine lens capsule basement collagen exerts a negative priming on polymorphonuclear neutrophils
55. The alpha 3 chain of type IV collagen prevents activation of human polymorphonuclear leukocytes
56. Identification of CD47/integrin-associated protein and αvβ3 as two receptors for the α3(IV) chain of type IV collagen on tumor cells
57. The α3(IV) 185-206 peptide from noncollagenous domain 1 of type IV collagen interacts with a novel binding site on the β3 subunit of integrin αvβ3 and stimulates focal adhesion kinase and phosphatidylinositol 3-kinase phosphorylation
58. New functions for noncollagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo
59. Distinct antitumor properties of a type IV collagen domain derived from basement membrane
60. Two RGD-independent αvβ3 integrin binding sites on tumstatin regulate distinct anti-tumor properties
61. Distribution of α1(IV) and α3(IV) chains of type IV collagen in lung tumours
62. Loss of alveolar basement membrane type IV collagen α3, α4, and α5 chains in bronchioalveolar carcinoma of the lung
63. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5
64. Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo
65. The 67-kDa enzymatically inactive alternatively spliced variant of β-galactosidase is identical to the elastin/laminin-binding protein
66. Membrane-bound protein kinase C modulates receptor affinity and chemotactic responsiveness of Lewis lung carcinoma sublines to an elastin-derived peptide
67. Tropoelastin and elastin degradation products promote proliferation of human astrocytoma cell lines
68. Identification and signal transduction mechanism of elastin peptide receptor in human leukocytes
69. Regulation of matrix metalloproteinase-2 (gelatinase A, MMP-2), membrane-type matrix metalloproteinase-1 (MT1-MMP) and tissue inhibitor of metalloproteinases-2 (TIMP-2) expression by elastin-derived peptides in human HT-1080 fibrosarcoma cell line
70. Cumulative influence of elastin peptides and plasminogen on matrix metalloproteinase activation and type I collagen invasion by HT-1080 fibrosarcoma cells
71. Conformational dependence of collagenase (matrix metalloproteinase-1) up-regulation by elastin peptides in cultured fibroblasts
72. Fibrillin degradation by matrix metalloproteinases: Implications for connective tissue remodeling
73. Human 92- and 72-kDa type IV collagenases are elastases
74. The second type II module from human matrix metalloproteinase 2: Structure, function and dynamics
75. Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase/type IV collagenase. High affinity binding to native type I collagen but not native type IV collagen
76. The involvement of the fibronectin type II-like modules of human gelatinase A in cell surface localization arid activation
77. Binding of 92 and 72 kDa progelatinases to insoluble elastin modulates their proteolytic activation
78. Human progelatinase A can be activated by autolysis at a rate that is concentration-dependent and enhanced by heparin bound to the C-terminal domain
79. LRP: A multifunctional scavenger and signaling receptor
80. Extracellular matrix metalloproteinase 2 levels are regulated by the low density lipoprotein-related scavenger receptor and thrombospondin 2
81. Thrombospondins as matricellular modulators of cell function
82. The cell biology of thrombospondin-1
83. The functions of thrombospondin-1 and -2
84. The localization of thrombospondin-1 (TSP-1), cysteine-serine-valine-threonine-cysteine-glycine (CSVTCG) TSP receptor, and matrix metalloproteinase-9 (MMP-9) in colorectal cancer
85. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1
86. Matricellular proteins as modulators of cell-matrix interactions: Adhesive defect in thrombospondin 2-null fibroblasts is a consequence of increased levels of matrix metalloproteinase-2
87. Thrombospondin type 1 repeats interact with matrix metalloproteinase 2. Regulation of metalloproteinase activity
88. Cellular internalization and degradation of thrombospondin-1 is mediated by the amino-terminal heparin binding domain (HBD): High affinity interaction ofdimeric HBD with the low density lipoprotein receptor-related protein
89. A novel mechanism for controlling the activity of alpha2-macroglobulin receptor/low density lipoprotein receptor-related protein: Multiple regulatory sites for 39-kDa receptor-associated protein
90. The tumor-promoting effect of wounding: A possible role for TGF-beta-induced stromal alterations
91. Mutant and genetically modified mice as models for studying the relationship between aging and carcinogenesis
92. Aging of connective tissues: From genetic to epigenetic mechanisms
93. A deficit in collagenase activity contributes to impaired migration of aged microvascular endothelial cells
94. Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility
95. Decreased contraction of glycated collagen lattices coincides with impaired matrix metalloproteinase production
96. In vitro glycoxidation alters the interactions between collagens and human polymorphonuclar leucocytes